US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
bioXXmed AG (T5O) 銘柄情報

bioXXmed AG (T5O)

0.00

0.00

(0.00%)

終了 7月13日 5:00AM

bioXXmed AG (T5O) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

平均取引量 (3 か月)

86 €

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

398.824k

前日終値

-

始値

-

時刻

最終取引時間

VWAP

-

歳入

16.73k

純利益

-365.39k

発行済株式数

271,865

浮動株比率 (%)

-

機関投資家保有比率 (%)

-

配当利回り

PER

-0.6

株価売上高倍率 (PSR)

13

1 株当たり利益 (EPS)

-1.34

ベータ

4.99

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its ... bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany. 詳細を表示

セクター

-

業界

-

ウェブサイト

bioxxmed.ag

本社

Heidelberg, Germany

設立

2026

bioXXmed AG is listed in the sector of the Tradegate (DE) with ticker T5O. The last closing price for bioXXmed was -. Over the last year, bioXXmed shares have traded in a share price range of 0.00 € to 0.00 €.

bioXXmed currently has 271,865 shares in issue. bioXXmed has a price to earnings ratio (PE ratio) of -0.60.

bioXXmed AG: Abschluss von Backstop-Vereinbarungen für Kapitalerhöhung aus genehmigtem Kapital

bioXXmed AG / Schlagwort(e): Sonstiges bioXXmed AG: Abschluss von Backstop-Vereinbarungen für Kapitalerhöhung...

bioxxmed AG setzt Kapitalherabsetzung um

bioXXmed AG / Schlagwort(e): Sonstiges bioxxmed AG setzt Kapitalherabsetzung um 09.08.2024 / 16:56 CET/CEST...

Aufsichtsrat Sören Rose tritt aus persönlichen Gründen zurück

bioXXmed AG / Schlagwort(e): Sonstiges Aufsichtsrat Sören Rose tritt aus persönlichen Gründen zurück...

Die 100%-ige Tochter der bioXXmed AG, rancoderm GmbH, übernimmt die wesentlichen Teile des Geschäftsbetriebs der insolventen DermaTools Biotech GmbH

bioXXmed AG / Schlagwort(e): Sonstiges Die 100%-ige Tochter der bioXXmed AG, rancoderm GmbH, übernimmt die...

bioXXmed AG übernimmt Vermögensgegenstände und Vertragsverhältnisse der insolventen DermaTools Biotech GmbH durch eine 100%-ige Tochtergesellschaft AG:

bioXXmed AG / Schlagwort(e): Sonstiges/Sonstiges bioXXmed AG übernimmt Vermögensgegenstände und...

bioXXmed AG: Asset-Deal

bioXXmed AG / Schlagwort(e): Sonstiges/Sonstiges bioXXmed AG: Asset-Deal 14.05.2024 / 19:35...

bioXXmed AG: Asset Deal

bioXXmed AG / Schlagwort(e): Sonstiges bioXXmed AG: Asset Deal 14.05.2024 / 18:06 CET/CEST Veröffentlichung...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

T5O - Frequently Asked Questions (FAQ)

What is the current bioXXmed AG share price?

The current share price of bioXXmed AG is 0.00 €

How many bioXXmed AG shares are in issue?

bioXXmed AG has 271,865 shares in issue

What is the 1 year trading range for bioXXmed AG share price?

bioXXmed AG has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of bioXXmed AG?

The price to earnings ratio of bioXXmed AG is -0.6

What is the cash to sales ratio of bioXXmed AG?

The cash to sales ratio of bioXXmed AG is 13

What is the registered address of bioXXmed AG?

The registered address for bioXXmed AG is Ziegelhäuser Landstraße 3, Heidelberg, 69120

What is the bioXXmed AG website address?

The website address for bioXXmed AG is bioxxmed.ag

lakers17

lakers17 5分前

NSAV and BCDS are connected whether you like it ot not. Get a new accountant and a new lead programmer and then there is no connection. Both worked for both companies and the connection is there along with being in crypto and doing many of the same things. If NSAV was allowed to continue many of

waterchaser

waterchaser 6分前

Pls define “soon”.
As in the second Tuesday of never?
PSRU is lost money.
https://investorshub.advfn.com/uimage/uploads/2018/3/20/picfxToilet_.png

newflow

newflow 6分前

No problem BOB, we all are grown ups, we agree to disagree. AI doesn't know about these cases unless you present the facts and feed its brain. It might take an year for me to go thru 7th amended plan and understand, or 10 years. For AI it might take less than a minute to parse thru, thats the beauty

cowtown jay

cowtown jay 6分前

I think he's more interested in SpongeTech, going forward. That judge told me that he thought I had a case, and Judge Cote acted on my input in regards to defendants in one of her cases.

flipper44

flipper44 7分前

I agree, and, I think this data analysis likely moves us beyond a conditional approval to an (expected) approval with some minor conditions. So instead of sausage making after an approval, it looks like it was done before that. This then presents a better window of time to speak with “interested pa

mick

happy sunday, we pray

fredscott36

fredscott36 8分前

....SO....losers...........WE SOLVED NAOMI.........next task............PEDDLE FCNCA FOR TOP DOLLAR.................???...............

.....FDIC is in charge of this, which worries us..........FDIC made some BIZARRE payola side deal with UBS, imo.........completely released UBS from a

Tr8dervic

Tr8dervic 8分前

mick

comeback rory, not enough

learningcurve2020

learningcurve2020 9分前

https://www.youtube.com/watch?v=50923VUWYOo&t=58s

https://www.youtube.com/watch?v=50923VUWYOo&t=58s

pqr

Formal: you overstate your point. In many persuasion event contexts it is tactical to add “more” evidence prior to a decision issuance. So here. That this was material expense to NWBO emphasizes that the company weighed the benefit and acted on this opportunity. I am confident that MHRA collaborate

Pittkid

Pittkid 11分前

BBANBOB

BBANBOB 11分前

Newflow
PLEASE do not take my comments as a SLAM on you OR THE MASSIVE WORKS YOU HAVE DONE HERE it is certainly not meant that way at all.
Keep up the work I love reading it but understand it then makes all that read it have questions about it.
Thanks again

P.S. T

02opida

02opida 11分前

SCTH , SEGG , TRWD

tedpeele

tedpeele 11分前

It would require an 8K

newflow

newflow 13分前

LG, 4) Not sure how the court could cancel all preferred and common stock prospectuses and all associated documents on the (ED) Effective Date of March 19, 2012 and leave some of the same documents in play for the Safe Harbor assets as this would create dual ownership of assets it would seem.

BBANBOB

BBANBOB 13分前

KeyKey

KeyKey 14分前

It seems like novascotiaSTS ( and Speaker :-) ) can hardly wait for the massive payouts coming their way :-)

BBANBOB

BBANBOB 14分前

newflow

THANK you as you just confirmed that WE PEONS have NO REAL IDEA what was negotiated

""" what were the terms and parties involved, no clue to public."""

And so with this being a FACT then in short AI doesn't know either correct? As it can only glea

campe

Well, not on Roku and Droid app not loading. Anyone seeing it on Roku or App or is it just me?

Nightdaytrader

Nightdaytrader 15分前

Yes, my only point is that AI is sometimes 100% correct, but sometimes, only partially correct. So AI is learning but a long ways from perfect. So we just need to keep double and triple checking what it's telling us... but as always, I appreciate NewFlow and everybody else who posts their thoug

jammy32

jammy32 15分前

My guess is Nasrat is holding out for a reputable pharmaceutical company to buy us with shares / stock. He doesn’t get hit with a big tax bill. He spends / sells what he needs and leave the rest to family. When he passes, the family get to take advantage of a loop hole (step up) and will owe ze

newflow

newflow 16分前

They used several vehicles BOB, we dont have any clues.

Eli's Gone

Eli's Gone 16分前

I'm in; 12-22-9-7

rakp

Thanks Gold, I missed that!

GraniteShares 3x Long Ro...

3625% until 03/03/2027

Bmo Harris Bank Na Point...

Banco De Sabadell (PK)

Netherlands Nl Strip 15j...

Ci Money Market Fund Cla...

KGHM Ploska Miedz (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。